|
[1]
|
Differential responses of bone to angiotensin II and angiotensin(1-7): beneficial effects of ANG(1-7) on bone with exposure to high glucose
American Journal of Physiology-Endocrinology and Metabolism,
2021
DOI:10.1152/ajpendo.00158.2020
|
|
|
|
|
[2]
|
Inhibition of tanshinone IIA on renin activity protected against osteoporosis in diabetic mice
Pharmaceutical Biology,
2020
DOI:10.1080/13880209.2020.1738502
|
|
|
|
|
[3]
|
Synthesis and Docking Study of Pyrimidine Derivatives Scaffold for Anti‐Hypertension Application
ChemistrySelect,
2019
DOI:10.1002/slct.201900799
|
|
|
|
|
[4]
|
Synthesis and Docking Study of Pyrimidine Derivatives Scaffold for Anti‐Hypertension Application
ChemistrySelect,
2019
DOI:10.1002/slct.201900799
|
|
|
|
|
[5]
|
Differential response of bone and kidney to ACEI in db/db mice: A potential effect of captopril on accelerating bone loss
Bone,
2017
DOI:10.1016/j.bone.2017.01.029
|
|
|
|
|
[6]
|
Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice
Osteoporosis International,
2016
DOI:10.1007/s00198-015-3348-y
|
|
|
|
|
[7]
|
Impairing effects of angiotensin-converting enzyme inhibitor Captopril on bone of normal mice
European Journal of Pharmacology,
2016
DOI:10.1016/j.ejphar.2015.12.011
|
|
|
|
|
[8]
|
Comparative study of interactions of aliskiren and AT 1 receptor antagonists with lipid bilayers
Biochimica et Biophysica Acta (BBA) - Biomembranes,
2015
DOI:10.1016/j.bbamem.2014.12.004
|
|
|
|
|
[9]
|
Renin Inhibition Improves Ovariectomy-Induced Osteoporosis of Lumbar Vertebra in Mice
Biological and Pharmaceutical Bulletin,
2014
DOI:10.1248/bpb.b14-00576
|
|
|
|
|
[10]
|
Ameliorative potential of aliskiren in experimental colitis in mice
European Journal of Pharmacology,
2014
DOI:10.1016/j.ejphar.2014.05.009
|
|
|
|
|
[11]
|
Potential of RAS Inhibition to Improve Metabolic Bone Disorders
BioMed Research International,
2013
DOI:10.1155/2013/932691
|
|
|
|